Alcon: Jefferies initiates coverage with 'buy' rating
(CercleFinance.com) - An analyst at Jefferies said on Monday that he is initiating his coverage of the Alcon share with a "buy" rating.
Note that the company was floated on the Zurich Stock Exchange last Tuesday, with an opening price of 55 Swiss francs.
"Our consumer and doctor surveys (released earlier), suggest substantial opportunity for PRECISION1 (daily lenses) and for AT-IOLs and PanOptix (cataract)," the broker said.
Jefferies has a target price of 70 dollars for the subsidiary of Novartis.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.